AC Immune SA (ACIU)
3.615
+0.22
(+6.32%)
USD |
NASDAQ |
Jan 22, 16:00
3.615
0.00 (0.00%)
After-Hours: 20:00
AC Immune Cash from Investing (Quarterly): 26.82M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BeOne Medicines Ltd. | -49.28M |
| CRISPR Therapeutics AG | -119.23M |
| Addex Therapeutics Ltd. | 0.0379M |
| NewCelX Ltd. | -- |
| Molecular Partners AG | 14.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -24.25M |
| Cash from Financing (Quarterly) | -0.337M |
| Free Cash Flow | -61.11M |
| Free Cash Flow Per Share (Quarterly) | -0.2414 |
| Free Cash Flow to Equity (Quarterly) | -24.03M |
| Free Cash Flow to Firm (Quarterly) | -24.30M |
| Free Cash Flow Yield | -16.83% |